Stocks and Investing Stocks and Investing
Tue, May 26, 2020
Mon, May 25, 2020
Fri, May 22, 2020
Thu, May 21, 2020
Wed, May 20, 2020

Leland Gershell Maintained (ASND) at Buy with Decreased Target to $208 on, May 20th, 2020


Published on 2024-10-27 06:44:34 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $219 to $208 on, May 20th, 2020.

Leland has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 0 agree with Leland's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Leland


  • Adam Walsh of "Stifel" Maintained at Strong Buy with Increased Target to $171 on, Monday, April 20th, 2020
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $201 on, Monday, April 20th, 2020
  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $180 on, Thursday, April 2nd, 2020

Similar Stocks and Investing Articles